Pharming Group N.V., a biopharmaceutical company, develops and commercialize protein replacement therapies and precision medicines for the treatment of rare diseases and unmet medical needs in the United States, Europe, and internationally. The company's lead product is Ruconest, a recombinant human C1 esterase inhibitor that is used for the treatment of acute hereditary angioedema. It also engages in the development of rhC1INH for the treatment of pre-eclampsia, acute kidney injury, and COVID-19; leniolisib, a phosphoinositide 3-kinase delta (PI3K delta) to treat patients with activated PI3K delta syndrome; and alpha-glucosidase therapy for the treatment of pompe and fabry diseases. The company has a development collaboration and license agreement with Novartis; and a strategic collaboration agreement with Orchard Therapeutics plc for research, development, manufacturing, and commercialization of OTL-105, an investigational ex-vivo autologous hematopoietic stem cell gene therapy for the treatment of hereditary angioedema. Pharming Group N.V. is headquartered in Leiden, the Netherlands. The 2025 version of the report offers detailed insights into the company's strategies, developments, outlook and drivers. In addition to SWOT Analysis and Financial Overview, the report analyzes key projects, business description, products, services, brands, operating locations, subsidiaries and affiliates of Pharming Group N.V. ADS each representing 10 ordinary shares.
Pharming Group N.V. ADS each representing 10 ordinary shares business operations across the value chain are included. Further, all major operating and planned locations, related contacts, details of subsidiaries and partnerships of Pharming Group N.V. ADS each representing 10 ordinary shares are also analyzed.
Detailed SWOT Analysis of the company including key strengths and weaknesses of Pharming Group N.V. ADS each representing 10 ordinary shares , on which it can build its business along with potential opportunities and threats in the near to medium term future are detailed.
Key employees of the company including the management team and board of directors are listed with their designations. Further, statistics on key parameters such as employee count, organization structure etc is provided.
Financial analysis of Pharming Group N.V. ADS each representing 10 ordinary shares including key ratios, income statement, cash flow statement and balance sheet are provided for the company. In addition, Key historical events, summary analysis of Pharming Group N.V. ADS each representing 10 ordinary shares and all latest updates of the company are provided.
The 2025 version of Pharming Group N.V. ADS each representing 10 ordinary shares report is presented after intensive primary and secondary research processes and it presents the insights in a complete impartial and reader friendly format.
TABLE OF CONTENTS
1.1 List of Tables
1.2 List of Figures
2 Introduction to the Company
2.1 Pharming Group N.V. ADS each representing 10 ordinary shares- Key Facts
2.2 Pharming Group N.V. ADS each representing 10 ordinary shares- Geographic Locations
2.3 Pharming Group N.V. ADS each representing 10 ordinary shares- Subsidiaries and Affiliates
2.4 Pharming Group N.V. ADS each representing 10 ordinary shares- Business Divisions
2.5 Pharming Group N.V. ADS each representing 10 ordinary shares- Key Employees
2.5.1 Management Team
2.5.2 Board of Directors
3. Pharming Group N.V. ADS each representing 10 ordinary shares Strategic Analysis Review
3.1 Pharming Group N.V. ADS each representing 10 ordinary shares- Key Strategies
3.2 Pharming Group N.V. ADS each representing 10 ordinary shares- Company Outlook Statement
3.3 Pharming Group N.V. ADS each representing 10 ordinary shares- SWOT Analysis
3.3.1 Pharming Group N.V. ADS each representing 10 ordinary shares- Key Strengths
3.3.2 Pharming Group N.V. ADS each representing 10 ordinary shares- Key Weaknesses
3.3.3 Pharming Group N.V. ADS each representing 10 ordinary shares- Potential Opportunities
3.3.4 Pharming Group N.V. ADS each representing 10 ordinary shares- Potential Threats
3.4 Pharming Group N.V. ADS each representing 10 ordinary shares- Key Competitors
4. Business Description of the Company
4.1 Pharming Group N.V. ADS each representing 10 ordinary shares- Business Overview
4.2 Pharming Group N.V. ADS each representing 10 ordinary shares- Operations by Segment
5 Products and Services Details
5.1 Pharming Group N.V. ADS each representing 10 ordinary shares- Key Products
5.2 Pharming Group N.V. ADS each representing 10 ordinary shares- Key Service Areas
5.3 Pharming Group N.V. ADS each representing 10 ordinary shares- Key Brands
6 Company Developments
6.1 Pharming Group N.V. ADS each representing 10 ordinary shares- Company History
6.2 Pharming Group N.V. ADS each representing 10 ordinary shares- Latest Developments
7 Financial Analysis
7.1 Pharming Group N.V. ADS each representing 10 ordinary shares- Income Statements
7.2 Pharming Group N.V. ADS each representing 10 ordinary shares- Balance Sheet
7.3 Pharming Group N.V. ADS each representing 10 ordinary shares- Cash Flow Statements
8 Competitors and Industry Analysis
8.1 Pharming Group N.V. ADS each representing 10 ordinary shares- Direct Competitors
8.2 Pharming Group N.V. ADS each representing 10 ordinary shares- Competitor Financial Ratios comparison
8.3 Pharming Group N.V. ADS each representing 10 ordinary shares- Competitor Stock Charts Comparison
8.4 Pharming Group N.V. ADS each representing 10 ordinary shares- Industry Analysis
9 Appendix
9.1 About SWOTreports
9.2 Sources and Methodology
9.3 Contact Information
P.S.Financial Analysis will be provided only for companies reporting financial data.
Get Free Sample
At SWOT Reports, we understand the importance of informed decision-making in today's dynamic business landscape. To help you experience the depth and quality of our market research reports, we offer complimentary samples tailored to your specific needs.
Start Now! Please fill the form below for your free sample.
Why Request a Free Sample?
Evaluate Our Expertise: Our reports are crafted by industry experts and seasoned analysts. Requesting a sample allows you to assess the depth of research and the caliber of insights we provide.
Tailored to Your Needs: Let us know your industry, market segment, or specific topic of interest. Our free samples are customized to ensure relevance to your business objectives.
Witness Actionable Insights: See firsthand how our reports go beyond data, offering actionable insights and strategic recommendations that can drive your business forward.
Embark on your journey towards strategic decision-making by requesting a free sample from SWOT Reports. Experience the caliber of insights that can transform the way you approach your business challenges.
FAQ's
Gain valuable insights into the company for academic or business research purposes with this comprehensive profile. Key elements, such as SWOT analysis and corporate strategy, are included to support your research needs effectively.
Customer and Supplier Identification: Analyze the company’s business structure, operations, major products, services, and strategies to identify potential customers and suppliers.
Leverage a detailed SWOT analysis to understand and evaluate your competitors' business structures, strategies, and core performance metrics. This analysis offers an up-to-date and objective perspective on the company’s strengths, weaknesses, opportunities, and threats.
Didn’t find what you’re looking for? TALK TO OUR ANALYST TEAM
Need something within your budget? NO WORRIES! WE GOT YOU COVERED!
Reach Out to Us
Industries
Resources
Company
Sign up for Offers & Promotions
- Connect with us
- +91 630 95 25755
- sales@swotreports.com
-
Chat on WhatsApp
